Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
Hematologic Oncology Update
00:00
Exploring Biospecific Antibodies and Treatment Options in Challenging Cases
This chapter covers the safety and effectiveness of biospecific antibodies in dialysis patients, highlighting recent studies that alleviate concerns over neurotoxicity. It also examines treatment alternatives for patients unable to tolerate maintenance therapy, focusing on proteasome inhibitors and monoclonal antibodies.
Transcript
Play full episode
